BV

Bobba Venkatadri

Active Director Director DIN 02272890
DIN 02272890 First appointment Apr 2008 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 3 active board seats
Past companies 12 historical roles
Total affiliations 15 Since Apr 2008
Shareholding value β€’β€’β€’β€’ Premium profile
Directorship timeline
First appointment 11 Apr 2008
Active appointments 10
Total timeline records 15

Bobba Venkatadri (DIN 02272890) has 15 recorded board appointments in Indian companies, the first from April 2008, of which 10 are current. The chart and the list below show each company, the role held and the years of the appointment, as filed with the Ministry of Corporate Affairs.

Appointment history

Since 2008
Patient Focus Private Limited Nominee Director · 2016 – present
Current
A.P.I.D.C. Venture Capital Private Limited Nominee Director · 2016 – present
Current
Cancer Genetics India Private Limited Additional Director · 2014 – present
Current
Sindu Pharmaceuticals Private Limited Director · 2013 – present
Current
Sindu Research Laboratories Private Limited Director · 2013 – present
Current
Richcore Enzymes Private Limited Director · 2013 – present
Current
Jaya Diagnostic And Research Centre Ltd Director · 2012 – present
Current
Napo Pharmaceuticals India Private Limited Director · 2008 – present
Current
Napo India Private Limited Director · 2008 – present
Current
Current
Previous
Diabetomics Medical Private Limited Nominee Director · 2017 – 2024
Previous
Healthvista India Private Limited Director · 2014 – 2017
Previous
Evolva Biotech Private Limited Nominee Director · 2012 – 2018
Previous
Laurus Bio Private Limited Nominee Director · 2012 – 2017
Previous

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available